Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
35.13
+0.89 (2.60%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Faeth Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Initiates $70 | Buy | Initiates | $70 | +99.26% | Sep 15, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $59 | Buy | Initiates | $59 | +67.95% | Sep 14, 2026 |
| BTIG | BTIG | Buy Maintains $55 | Buy | Maintains | $55 | +56.56% | Sep 14, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 9, 2026 |
| Needham | Needham | Buy Initiates $56 | Buy | Initiates | $56 | +59.41% | Aug 21, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +70.79% | Aug 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 | Buy | Maintains | $60 | +70.79% | Aug 5, 2026 |
| JonesTrading | JonesTrading | Buy Initiates $55 | Buy | Initiates | $55 | +56.56% | Aug 4, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.